Solara Active Pharma Sciences Limited
⚠️ Moderate Risk
FEI: 3003585876 • Cuddalore, Tamil Nadu • INDIA
FEI Number
3003585876
Location
Cuddalore, Tamil Nadu
Country
INDIAAddress
A - 1/B Sipcot Industrial Complex, Kudikadu Village, Cuddalore, Tamil Nadu, India
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/2/2014 | 61MCS42LEVETIRACETAM (ANTI-CONVULSANT) | New Orleans District Office (NOL-DO) | |
| 12/17/2012 | 62BCS13COLESEVELAM HYDROCHLORIDE (ANTI-HYPERLIPIDEMIC) | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
| 7/23/2008 | 62OCS38ISRADIPINE (ANTI-HYPERTENSIVE - PART II) | 16DIRECTIONS | New York District Office (NYK-DO) |
| 5/5/2008 | 62OCS38ISRADIPINE (ANTI-HYPERTENSIVE - PART II) | 16DIRECTIONS | New York District Office (NYK-DO) |
| 5/5/2008 | 62OCS38ISRADIPINE (ANTI-HYPERTENSIVE - PART II) | 16DIRECTIONS | New York District Office (NYK-DO) |
| 4/29/2008 | 62OCS38ISRADIPINE (ANTI-HYPERTENSIVE - PART II) | 16DIRECTIONS | New York District Office (NYK-DO) |
| 4/29/2008 | 62OCS38ISRADIPINE (ANTI-HYPERTENSIVE - PART II) | 16DIRECTIONS | New York District Office (NYK-DO) |
| 11/27/2007 | 62TCU03NIZATIDINE (ANTI-SECRETORY) | 16DIRECTIONS | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Solara Active Pharma Sciences Limited's FDA import refusal history?
Solara Active Pharma Sciences Limited (FEI: 3003585876) has 8 FDA import refusal record(s) in our database, spanning from 11/27/2007 to 4/2/2014.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Solara Active Pharma Sciences Limited's FEI number is 3003585876.
What types of violations has Solara Active Pharma Sciences Limited received?
Solara Active Pharma Sciences Limited has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Solara Active Pharma Sciences Limited come from?
All FDA import refusal data for Solara Active Pharma Sciences Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.